News Releases
- March 9, 2021Annovis Bio to Present at the H.C. Wainwright Global Life Sciences Conference
- February 16, 2021Annovis Bio to Present at the BIO CEO & Investor Digital Conference
- February 4, 2021Annovis Bio Receives European Patent for Method of Treating Acute Nerve and Brain Insults
- February 2, 2021Annovis Bio's Lead Candidate ANVS401 Improves Cognitive and Functional Outcomes in Stroke Mice Study
- January 5, 2021Annovis Bio to Present at H.C. Wainwright BioConnect 2021 Conference
- December 17, 2020Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report
- December 15, 2020Annovis Bio Showcases its Unique Approach to Alzheimer’s at the New York Academy of Sciences
- December 7, 2020Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020
- December 3, 2020Annovis Bio to Present at the New York Academy of Sciences’ Alzheimer's Disease Therapeutics: Alternatives to Amyloid 2020 Virtual Conference
- November 16, 2020Annovis Bio to Participate in A.G.P.'s Virtual Healthcare Symposium
- May 4, 2022Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
- April 28, 2022Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging
- April 11, 2022Annovis Bio to Participate in World Parkinson's Day to Raise Awareness on the Debilitating Disease
Media Coverage
- March 11, 2022Biotech IQ Podcast: Is axonal transport the key to solving neurodegenerative diseases? Maria Maccechini, PhD - CEO, Annovis Bio
- February 24, 2022Alzhemier's Speaks Radio: Annovis, a Biotech Company, Shares Updates on Their Research
- February 04, 2022Finding Genius Podcast: Understanding Neurodegenerative Diseases and the Links Between Parkinson"s and Alzheimer"s Disease with Dr. Cheng Fang
Events & Presentations
Filings
Filings
Description
Date Filed
Available Formats
E-mail Alerts
Back to Top